{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shiau S"],"funding":["NCATS NIH HHS","NIDA NIH HHS"],"pagination":["100017"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12709593"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["1(3)"],"pubmed_abstract":["<h4>Background</h4>There is longstanding concern that people with HIV receive prescription opioids at higher rates and have a disproportionate burden of opioid use disorder (OUD) compared with their counterparts without HIV. We aimed to evaluate trends of opioid prescriptions and indicators of OUD in an understudied but growing population of older adults with HIV.<h4>Methods</h4>For this retrospective repeated cross-sectional study, we constructed annual cohorts through a nationally representative sample of fee-for-service Medicare beneficiaries aged 65 years and older in the USA with Part D coverage (ie, prescription drug) enrolled between Jan 1, 2008, and Dec 31, 2021. Beneficiaries were eligible for inclusion in each cross-sectional cohort if they had reached the age of 65 years by Jan "],"journal":["The Lancet. Primary care"],"pubmed_title":["Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional study."],"pmcid":["PMC12709593"],"funding_grant_id":["UM1 TR004789","UL1 TR003017","R01 DA057568","K01 DA053157"],"pubmed_authors":["Getz K","Martins SS","Crystal S","Shiau S","Kinkade CW","Bender AA","Bennett L","Halkitis PN","Gerhard T","Yin MT","Drago F","Samples H","Dave C","Bushnell G","Roy JA"],"additional_accession":[]},"is_claimable":false,"name":"Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional study.","description":"<h4>Background</h4>There is longstanding concern that people with HIV receive prescription opioids at higher rates and have a disproportionate burden of opioid use disorder (OUD) compared with their counterparts without HIV. We aimed to evaluate trends of opioid prescriptions and indicators of OUD in an understudied but growing population of older adults with HIV.<h4>Methods</h4>For this retrospective repeated cross-sectional study, we constructed annual cohorts through a nationally representative sample of fee-for-service Medicare beneficiaries aged 65 years and older in the USA with Part D coverage (ie, prescription drug) enrolled between Jan 1, 2008, and Dec 31, 2021. Beneficiaries were eligible for inclusion in each cross-sectional cohort if they had reached the age of 65 years by Jan ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-11T05:07:01.448Z","creation":"2026-06-11T03:08:06.505Z"},"accession":"S-EPMC12709593","cross_references":{"pubmed":["41416251"],"doi":["10.1016/j.lanprc.2025.100017"]}}